Circulating complement (C3 and C4) for differentiation of SIRS from sepsis

Advances in Therapy

Volumn 23, Issue 6, 2006, Pages 893-901

  Sungurtekin, Hülya ^a,b   Sungurtekin, Ugur ^a   Balci, Canan ^a  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Complement; Sepsis; SIRS

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CRITICAL ILLNESS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT;

EID: 33847376808     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850211     Document Type: Article

References (26)

1. Bossink AWJ, Groeneveld ABJ, Hack CE, Thijs LG. The clinical host response to microbial infection in medical patients with fever. Chest. 1999;116:380-390.
2. 1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis. 1999;29:398-407.
3. Balci C, Sungurtekin H, Gurses E, Sungurtekin U, Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care. 2003;7:85-90.
4. Katja B, Hartmut K, Pawel M, Stefan B, Kox WJ, Spies CD. The value of immune modulating parameters in predicting the progression from peritonitis to septic shock. Shock. 2001;15:95-100.
5. Groeneveld AB, Bossink AW, van Mierlo GJ, Hack CE. Circulating inflammatory mediators in patients with fever: predicting bloodstream infection. Clin Diagn Lab Immun. 2001;8:1189-1195.
6. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993;119:771-778.
7. Hack CE, Nuijens JH, Felt-Bersma RJF, et al. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med. 1989;86:20-26.
8. Gardinali M, Padalino P, Vesconi S, et al. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis: correlation with severity of disease. Arch Surg. 1992;127:1219-1224.
9. Stove S, Welte T, Wagner TO, et al. Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome. Clin Diagn Lab Immunol. 1996;3:175-183.
10. Damas P, Canivet JL, deGroote D, et al. Sepsis and serum cytokine concentrations. Crit Care Med. 1997;25:405-412.
11. Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Kohl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med. 2000;28:2793-2798.
12. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-1655.
13. Oberhoffer M, Karzai W, Meier-Hellmann A, Bogel D, Fassbinder J, Reinhart K. Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis. Crit Care Med. 1999;27:1814-1818.
14. Ember JA, Hugli TE. Complement factors and their receptors. Immunopharmacology. 1997;38:3-15.
15. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality. Chest. 1993;103:565-575.
16. Heideman M, Hugli TE. Anaphylatoxin generation in multisystem organ failure. J Trauma. 1984;24:1038-1043.
17. Groeneveld ABJ, Tacx AN, Bossink AWJ, van Mierlo GJ, Hack CE. Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection. Clin Immunol. 2003;106:106-115.
18. Nakae H, Endo S, Inada K, Yoshida M. Chronological changes in the complement system in sepsis. Surg Today. 1996;26:225-229.
19. Kang HJ, Kim JH, Lee EH, Lee YK, Hur M, Lee KM. Change of complement system predicts the outcome of patients with severe thermal injury. J Burn Care Rehabil. 2003;24:148-153.
20. Messias-Reason IJ, Hayashi SY, Nisihara RM, Kirschfink M. Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis. Clin Exp Immunol. 2002;127:310-315.
21. Hecke F, Schmidt U, Kola A, Bautsch W, Klos A, Kohl J. Circulating complement proteins in multiple trauma patients: correlation with injury severity, development of sepsis, and outcome. Crit Care Med. 1997;25:2015-2024.
22. Vanderschueren S, DeWeerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med. 2000;28:1871-1876.
23. Boldt J, Menges T, Wollbruck M, Sonneborn S, Hempelmann G. Platelet function in critically ill patients. Chest. 1994;106:899-903.
24. Stephan F, Montblanc JD, Cheffi A, Bonnet F. Thrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirements. Crit Care. 1999;3:151-158.
25. Stephan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahault A. Thrombocytopenia in a surgical ICU. Chest. 1999;115:1363-1370.
26. Riedler GF, Straub PW, Frick PG. Thrombocytopenia in septicemia: a clinical study for the evaluation of its incidence and diagnostic value. Helv Med Acta. 1971;36:23-38.